[Edematous maculopathies and piribedil].
D000328:Adult; D000368:Aged; D002829:Choroid; D003119:Color Perception Tests; D004149:Dioxoles / Q000627:therapeutic use; D004361:Drug Tolerance; D004487:Edema / Q000188:drug therapy*; D005122:Exudates and Transudates; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D008266:Macula Lutea; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use; D012162:Retinal Degeneration / Q000188:drug therapy; D012164:Retinal Diseases / Q000188:drug therapy; D012171:Retinal Vessels; D013924:Thrombophlebitis / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014792:Visual Acuity; D014794:Visual Fields
D004149:Dioxoles; D010879:Piperazines; D011743:Pyrimidines; D014665:Vasodilator Agents
Maculopathies oedémateuses et piribedil